Medivir AB (publ) (STO:MVIR)
Sweden · Delayed Price · Currency is SEK 1.604
-0.106 (-6.20%)
At close: Feb 27, 2026
Medivir AB Market Cap
Medivir AB has a market cap or net worth of 864.03 million as of February 27, 2026. Its market cap has increased by 227.79% in one year.
Market Cap
864.03M
Enterprise Value
753.03M
Revenue
8.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.60
Market Cap Chart
Since April 30, 1999, Medivir AB's market cap has increased from 643.11M to 864.03M, an increase of 34.35%. That is a compound annual growth rate of 1.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 864.03M | 370.84% |
| Dec 30, 2025 | 183.51M | -42.39% |
| Dec 30, 2024 | 318.56M | 100.20% |
| Dec 29, 2023 | 159.12M | -71.16% |
| Dec 30, 2022 | 551.67M | -11.61% |
| Dec 30, 2021 | 624.11M | 209.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Egetis Therapeutics AB | 1.81B |
| BioInvent International AB | 1.53B |
| Cantargia AB | 1.18B |
| Genovis AB (publ.) | 1.14B |
| Xspray Pharma AB | 1.09B |
| SynAct Pharma AB | 1.05B |
| Infant Bacterial Therapeutics AB | 677.61M |
| FluoGuide | 585.31M |